Gemini Bioproducts, LLC
PrivateLast Round
Early Funding
Nov 4, 2021
Company Overview
Gemini Bioproducts, LLC operates in Healthcare & Life Sciences and is based in West Sacramento, California. Its latest recorded funding round was an Early Funding round in November 2021.
Gemini Bioproducts, LLC is a biotechnology company that manufactures and supplies cell culture reagents, sera, and process liquids for the global biotechnology and biopharmaceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gemini Bioproducts, LLC Comparables
Compare Gemini Bioproducts, LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biowest | 84% | |
| Nucleus Biologics | 83% | |
| PAN-Biotech GmbH | 83% |
For institutional investors. Book with your work email.
Gemini Bioproducts, LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 4, 2021 | ||||
| Buyout/LBO | Sep 14, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gemini Bioproducts, LLC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BelHealth Investment Partners | Buyout/LBO |
| BroadOak Capital Partners | Early Funding, Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors increased 43% MoM, reaching 11.3K.
- Jan 2, 2026
Monthly visitors grew 98% MoM, reaching 10.6K.
For institutional investors. Book with your work email.
Gemini Bioproducts, LLC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gemini Bioproducts, LLC's valuation, stock price, and market status.
Is Gemini Bioproducts, LLC a public or private company?
Gemini Bioproducts, LLC is a private company.
What is the current stock price of Gemini Bioproducts, LLC?
Gemini Bioproducts, LLC is a private company, so its shares have no public market price. Caplight tracks Gemini Bioproducts, LLC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gemini Bioproducts, LLC worth (valuation)?
Valuation information for Gemini Bioproducts, LLC is not publicly available.
Can I buy Gemini Bioproducts, LLC stock?
Gemini Bioproducts, LLC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gemini Bioproducts, LLC's last funding round?
Gemini Bioproducts, LLC's most recent funding round was Early Funding on November 4, 2021.
Who are the main investors in Gemini Bioproducts, LLC?
Key investors in Gemini Bioproducts, LLC include BelHealth Investment Partners, BroadOak Capital Partners.
Will Gemini Bioproducts, LLC IPO soon?
No public IPO plans have been announced for Gemini Bioproducts, LLC.
How can I track Gemini Bioproducts, LLC secondary market activity?
Caplight tracks bids, offers, and trades in Gemini Bioproducts, LLC's shares on secondary markets.